Purchases and Sales Made in Q3 2023 in Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW) during Q3 2023. The information is specifically focused on institutions that hold shares of NEUROSENSE THERAPEUTICS LTD WT.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
BUY
|
- |
3.8KNew |
$418 - $1.06K
|
3.8K
$760
|
|
Nov 13, 2023
Q3 2023
|
Clear Street LLC
|
BUY
|
- |
600+ 1.02% |
$66 - $168
|
59.3K
$11.9K
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2023
Q3 2023
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-981- 1.12% |
$108 - $275
|
86.8K
$17.4K
|
|
Nov 13, 2023
Q3 2023
|
Warberg Asset Management LLC
Winnetka, IL |
SELL
|
- |
-1.6K- 2.06% |
$176 - $448
|
76.1K
$15.2K
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-26.3K- 69.45% |
$2.9K - $7.38K
|
11.6K
$2.32K
|